Buy Crypto Markets Spot FuturesZEC Earn Event Center Rewards Hub

Processa Pharmaceuticals, Inc. (PCSA)

NASDAQ

$2.04

$+0.03

(+1.46%)

Pre-Market

Processa Pharmaceuticals, Inc. (PCSA) Live Price Chart

Last updated: ⁦2026-09-08 10:19:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Processa Pharmaceuticals, Inc. (PCSA) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $2.04, with a market capitalization of $5.75M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.67 to $14.24. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$5.75M
Open	$2.02
Day's High	$938,350.00
Day's Low	$1.67
Previous Close	$2.05
Volume	12.16K
Average Volume	241.98K
P/E Ratio	--
52-Week High	$14.24
52-Week Low	$1.67
Dividend Yield	--
Earnings Date	--

Processa Pharmaceuticals, Inc. (PCSA) Pre-Market Stock Price

Processa Pharmaceuticals, Inc. (PCSA) is trading at $2.05 in pre-market trading as of 2026-09-04 23:31:00, unchanged from the previous close of $2.05

Pre-market trading shows how investors are pricing PCSA before the regular session opens. The current pre-market price is near the previous close, indicating neutral early trading sentiment.

Processa Pharmaceuticals, Inc. (PCSA) 7-Day Stock Price Change

Over the past seven days, Processa Pharmaceuticals, Inc. (PCSA) moved from $2.11 to $2.04, representing a decline of 3.32% ($0.07).

The stock traded between $2.01 and $2.20 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.

The average daily volume was 13.01 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

PCSA 52-Week Price Position

Position in Range: 2.9%

52W Low$1.67

52W High$14.24

PCSA is currently trading at $2.04, placing it 2.9% of the way from its 52-week low of $1.67 to its 52-week high of $14.24. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Processa Pharmaceuticals, Inc. (PCSA)?

Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its regulatory science approach in the development of Next Generation Chemotherapy (NGC) oncology drug products. The company's strategic prioritization is to advance its pipeline of NGC proprietary small-molecule oncology drugs. The NGC products are new chemical entities, but the company works by changing the metabolism, distribution, and/or elimination of already FDA-approved cancer drugs or their active metabolites while maintaining the mechanism of how the drug kills cancer cells. The four NGC treatments in its pipeline are PCS6422 (also referred to as NGC-Cap), PCS11T, also referred to as NGC-Iri, is an analog of SN38, and PCS11T, PCS12852, and PCS499.

Processa Pharmaceuticals, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	12
Exchange	NASDAQ
Company Website	https://www.processapharmaceuticals.com

How to Buy Processa Pharmaceuticals, Inc. (PCSA) Stock on MEXC

Eligible investors can buy real shares of Processa Pharmaceuticals, Inc. (PCSA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for PCSA and Place Your Order

Open the RealStocks trading page and search for PCSA. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Processa Pharmaceuticals, Inc. (PCSA) stock price today?

Processa Pharmaceuticals, Inc. (PCSA) is currently trading at $ 2.04, down 0.49% ($0.01) from the previous close of $ 2.05. Intraday prices update in real time during regular trading hours.

2.Is PCSA stock going up or down today?

As of 2026-09-04 23:31:00, PCSA is trading at $ 2.04, down 0.49% ($0.01) from its previous close of $ 2.05. The stock has traded between $ 1.67 and $ 938,350.00 during today’s regular session. Past price movements do not guarantee future results.

3.What is PCSA pre-market price?

As of 2026-09-04 23:31:00, PCSA is trading at $ 2.05 in pre-market trading, unchanged from the previous close of $ 2.05. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is PCSA after-hours price?

As of 2026-09-04 23:31:00, PCSA is trading at $ 2.04 in after-hours trading, down 0.49% ($0.01) from the regular-session close of $ 2.05. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is PCSA stock trading now?

PCSA trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does PCSA sit relative to its 52-week high and low?

Over the past 52 weeks, PCSA has traded between a low of $ 1.67 and a high of $ 14.24. At $ 2.04, the stock is positioned 2.9% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Processa Pharmaceuticals, Inc. in?

Processa Pharmaceuticals, Inc. (PCSA) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Processa Pharmaceuticals, Inc.'s market capitalization and where is it listed?

Processa Pharmaceuticals, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 5.75M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is PCSA valued in terms of P/E ratio and EPS?

PCSA trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Processa Pharmaceuticals, Inc. pay a dividend?

Processa Pharmaceuticals, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.